DXCM : Summary for DexCom, Inc. - Yahoo Finance

U.S. Markets closed

DexCom, Inc. (DXCM)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.01+0.40 (+0.62%)
At close: 4:00 PM EST

65.01 0.00 (0.00%)
After hours: 4:28 PM EST

People also watch:
PODDNUVAABMDELGXNXTM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close64.61
Open64.46
Bid65.05 x 200
Ask84.50 x 100
Day's Range64.24 - 65.64
52 Week Range47.92 - 96.38
Volume711,072
Avg. Volume1,209,721
Market Cap5.49B
Beta0.51
PE Ratio (TTM)-95.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is DexCom, Inc. (DXCM) A Good Stock To Buy?
    Insider Monkey8 days ago

    Is DexCom, Inc. (DXCM) A Good Stock To Buy?

    Insider Monkey finished processing more than 700 13F filings made by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of September 30. In this article we are going to take a look at smart money sentiment towards DexCom, Inc. (NASDAQ:DXCM). DexCom, Inc. (NASDAQ:DXCM) shareholders have witnessed an increase in hedge […]

  • MarketWatch8 days ago

    6 stocks to watch

    An old Wall Street saying is that a rising tide lifts all boats, but no matter which way the market is moving, there are stocks that will always go their own way. Here are six worth watching regardless ...

  • Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects
    Insider Monkey24 days ago

    Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects

    March Altus Capital Management is a Connecticut-based long/short equity hedge fund that primarily invests in healthcare stocks. The fund was started in 2012 by Neil Shah, a former healthcare manager at Shumway Capital Partners. According to March Altus Capital Management’s latest 13F filing, its U.S public equity portfolio was worth only $16 million at the […]